Literature DB >> 8545887

Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes.

L Lu1, D McCaslin, T E Starzl, A W Thomson.   

Abstract

The functional maturation of dendritic cells (DC) and other antigen-presenting cells is believed to reflect the upregulation of cell surface major histocompatibility complex (MHC) class II and other T cell co-stimulatory molecules, especially the CD28 ligands B7-1 (CD80) and B7-2 (CD86). In this study, we propagated cells exhibiting characteristics of DC precursors from the bone marrow (BM) of B10 mice (H-2b; I-A+) in response to granulocyte-macrophage colony stimulating factor (GM-CSF). The methods used were similar to those employed previously to propagate DC progenitors from normal mouse liver. Cells expressing DC lineage markers (NLDC 145+, 33D1+, N418+) harvested from 8-10-day GM-CSF stimulated BM cell cultures were CD45+, heat-stable antigen+, CD54+, CD44+, MHC class II+, B7-1dim but B7-2- (costimulatory molecule-deficient). Supplementation of cultures with interleukin-4 (IL-4) in addition to GM-CSF however, resulted in marked upregulation of MHC class II and B7-2 expression. These latter cells exhibited potent allostimulatory activity in primary mixed leukocyte cultures. In contrast, the cells stimulated with GM-CSF alone were relatively weak stimulators and induced alloantigen-specific hyporesponsiveness in allogeneic T cells (C3H; H-2k; I-E+) detected upon restimulation in secondary MLR. This was associated with blockade of IL-2 production. Reactivity to third-party stimulators was intact. The hyporesponsiveness induced by the GM-CSF stimulated, costimulatory molecule-deficient cells was prevented by incorporation of anti-CD28 monoclonal antibody in the primary MLR and was reversed by addition of IL-2 to restimulated T cells. The findings show that MHC class II+ B7-2- cells with a DC precursor phenotype can induce alloantigen-specific hyporesponsiveness in vitro. Under the appropriate conditions, such costimulatory molecule-deficient cells could contribute to the induction of donor-specific unresponsiveness in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545887      PMCID: PMC3000171          DOI: 10.1097/00007890-199560120-00028

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  47 in total

Review 1.  The dendritic cell system and its role in immunogenicity.

Authors:  R M Steinman
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Induction of immunological tolerance by porcine liver allografts.

Authors:  R Y Calne; R A Sells; J R Pena; D R Davis; P R Millard; B M Herbertson; R M Binns; D A Davies
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

3.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.

Authors:  T Lindstein; C H June; J A Ledbetter; G Stella; C B Thompson
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

4.  Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen.

Authors:  M T Crowley; K Inaba; M D Witmer-Pack; S Gezelter; R M Steinman
Journal:  J Immunol Methods       Date:  1990-10-04       Impact factor: 2.303

5.  Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.

Authors:  J D Fraser; B A Irving; G R Crabtree; A Weiss
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

6.  Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element.

Authors:  C L Verweij; M Geerts; L A Aarden
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

7.  Rat dendritic cells function as accessory cells and control the production of a soluble factor required for mitogenic responses of T lymphocytes.

Authors:  W E Klinkert; J H LaBadie; J P O'Brien; C F Beyer; W E Bowers
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation.

Authors:  J M Austyn; R M Steinman; D E Weinstein; A Granelli-Piperno; M A Palladino
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

9.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  52 in total

1.  Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.

Authors:  Y Morita; J Yang; R Gupta; K Shimizu; E A Shelden; J Endres; J J Mulé; K T McDonagh; D A Fox
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.

Authors:  V Bronte; D B Chappell; E Apolloni; A Cabrelle; M Wang; P Hwu; N P Restifo
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

Review 3.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

4.  Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.

Authors:  Mao-Meng Tiao; Lina Lu; Ran Tao; Lianfu Wang; John J Fung; Shiguang Qian
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 5.  The innate immune system in allograft rejection and tolerance.

Authors:  David F LaRosa; Adeeb H Rahman; Laurence A Turka
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

Review 6.  The lost chord: microchimerism and allograft survival.

Authors:  T E Starzl; A J Demetris; N Murase; M Trucco; A W Thomson; A S Rao
Journal:  Immunol Today       Date:  1996-12

Review 7.  Chimerism after organ transplantation.

Authors:  T E Starzl; A J Demetris; N Murase; M Trucco; A W Thomson; A S Rao; J J Fung
Journal:  Curr Opin Nephrol Hypertens       Date:  1997-05       Impact factor: 2.894

8.  Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts.

Authors:  F Fu; Y Li; S Qian; L Lu; F D Chambers; T E Starzl; J J Fung; A W Thomson
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

9.  CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

Authors:  J X Gao; J Madrenas; W Zeng; M J Cameron; Z Zhang; J J Wang; R Zhong; D Grant
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

10.  Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner.

Authors:  Guoping Jiang; Horng-Ren Yang; Lianfu Wang; Gary M Wildey; John Fung; Shiguang Qian; Lina Lu
Journal:  Transplantation       Date:  2008-12-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.